2014 annual financial data

Viridian Therapeutics 2014 Net margin

Direct answer

Net margin was -182.64%.

Operating income was -6.87M USD and net income was -7.89M USD.
Operating cash flow was -2.21M USD.

Get free Viridian Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
4.32M USD
Operating income
-6.87M USD
Net income
-7.89M USD
Operating cash flow
-2.21M USD